|
NDFIP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.82630000000028E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.097200E-03 |
| Normal-vs-Stage2 |
3.186000E-01 |
| Normal-vs-Stage3 |
8.368000E-04 |
| Normal-vs-Stage4 |
1.89139999995369E-06 |
| Stage1-vs-Stage2 |
4.477600E-01 |
| Stage1-vs-Stage3 |
2.005800E-01 |
| Stage1-vs-Stage4 |
1.010330E-02 |
| Stage2-vs-Stage3 |
1.430160E-01 |
| Stage2-vs-Stage4 |
2.328000E-02 |
| Stage3-vs-Stage4 |
3.592600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.416400E-04 |
| Normal-vs-AfricanAmerican |
3.08589999997722E-06 |
| Normal-vs-Asian |
8.199200E-01 |
| Caucasian-vs-AfricanAmerican |
4.752200E-02 |
| Caucasian-vs-Asian |
4.787000E-01 |
| AfricanAmerican-vs-Asian |
9.996500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77900000000375E-05 |
| Normal-vs-Female |
4.341200E-03 |
| Male-vs-Female |
3.880400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30149999999041E-05 |
| Normal-vs-Age(41-60Yrs) |
6.846000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.764700E-04 |
| Normal-vs-Age(81-100Yrs) |
5.043400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.848000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.654000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.671800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.736000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.704000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.096000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.810000E-02 |
| Normal-vs-Grade 2 |
4.348300E-02 |
| Normal-vs-Grade 3 |
2.780500E-04 |
| Normal-vs-Grade 4 |
1.70189973225376E-10 |
| Grade 1-vs-Grade 2 |
4.548400E-01 |
| Grade 1-vs-Grade 3 |
9.913200E-01 |
| Grade 1-vs-Grade 4 |
4.687600E-02 |
| Grade 2-vs-Grade 3 |
1.736600E-01 |
| Grade 2-vs-Grade 4 |
1.63610000003533E-06 |
| Grade 3-vs-Grade 4 |
1.047370E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.456200E-01 |
| Normal-vs-ccB subtype |
3.37370000003112E-06 |
| ccA subtype-vs-ccB subtype |
1.75748999999836E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.458680E-03 |
| Normal-vs-N1 |
7.660300E-03 |
| N0-vs-N1 |
1.506620E-01 |
|
|
